Habib Moshref Razavi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Habib Moshref Razavi has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
David G. McCormack
5 shared publicationsSanjay Mehta
5 shared publicationsSean Weicker
5 shared publications- Eric McGinnis
Cytogenomics Laboratory, Department of Pathology and Laboratory Medicine Vancouver General Hospital Vancouver British Columbia Canada
3 shared publications Le Feng Wang
Vascular Biology Group, Lawson Health Research Institute, Division of Respirology, Departments of Medicine, Physiology, and Pharmacology, London Health Sciences Center, University of Western Ontario, London, Ontario, Canada
3 shared publications- Lih Kuo
Department of Medical Physiology, Cardiovascular Research Institute, College of Medicine, Texas A&M University Health Science Center, Bryan, Texas 77807, USA, USA
3 shared publications
Latest Publications
- Open Access
- 12 July 2026
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 198 (26) , E1046-E1047
Un homme de 51 ans atteint d’une fièvre récurrente transmise par les tiques
- 12 July 2026
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 198 (26) , E1046-E1047
Open AccessUn homme de 51 ans atteint d’une fièvre récurrente transmise par les tiques
- Open Access
- 18 May 2026
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 198 (19) , E746
A 51-year-old man with tick-borne relapsing fever
- 18 May 2026
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 198 (19) , E746
Open AccessA 51-year-old man with tick-borne relapsing fever
- Open Access
- 15 March 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (6) , 2654
Activation of Smooth Muscle Kir2.1 Channels and Na+/K+-ATPase Mediates Dilation of Porcine Coronary Arterioles at Physiological Levels of Potassium
Metabolic stress on the heart can cause dilation of coronary arterioles for blood flow recruitment. Although potassium ions (K+) released from the myocardium are a major mediator for this response, the underlying signaling pathways for vasodilation are incompletely understood. Herein, the roles of smooth muscle inward-rectifier K+ channel subtype 2.1 (Kir2.1) and Na+/K+-ATPase were examined. Porcine coronary arterioles were isolated, cannulated, and pressurized for vasomotor study. Vessels developed basal tone and dilated concentration-dependently to extraluminal K+ from 7 to 20 mM. Higher K+ concentrations (25–40 mM) caused graded vasoconstriction. Vasodilation to K+ (10 mM) was not altered by endothelial removal, and blockade of ATP-sensitive K+ channels, voltage-sensitive K+ channels, or calcium-activated K+ channels did not affect K+-induced vasodilation. However, sustained but not abrupt transient vasodilation to K+ was reduced by the nonspecific Kir channel inhibitor Ba2+ or Kir2.1 channel blocker chloroethylclonidine. The Na+/K+-ATPase inhibitor ouabain attenuated K+-elicited vasodilation, and ouabain with Ba2+ abolished the response. Transfection of arterioles with Kir2.1 antisense oligonucleotides abolished sustained but not transient dilation. It is concluded that extraluminal K+ elevation within the physiological range induces initial transient dilation of porcine coronary arterioles by activating smooth muscle Na+/K+-ATPase and sustained dilation via smooth muscle Kir2.1 channels.
- 15 March 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (6) , 2654
Open AccessActivation of Smooth Muscle Kir2.1 Channels and Na+/K+-ATPase Mediates Dilation of Porcine Coronary Arterioles at Physiological Levels of Potassium
Metabolic stress on the heart can cause dilation of coronary arterioles for blood flow recruitment. Although potassium ions (K+) released from the myocardium are a major mediator for this response, the underlying signaling pathways for vasodilation are incompletely understood. Herein, the roles of smooth muscle inward-rectifier K+ channel subtype 2.1 (Kir2.1) and Na+/K+-ATPase were examined. Porcine coronary arterioles were isolated, cannulated, and pressurized for vasomotor study. Vessels developed basal tone and dilated concentration-dependently to extraluminal K+ from 7 to 20 mM. Higher K+ concentrations (25–40 mM) caused graded vasoconstriction. Vasodilation to K+ (10 mM) was not altered by endothelial removal, and blockade of ATP-sensitive K+ channels, voltage-sensitive K+ channels, or calcium-activated K+ channels did not affect K+-induced vasodilation. However, sustained but not abrupt transient vasodilation to K+ was reduced by the nonspecific Kir channel inhibitor Ba2+ or Kir2.1 channel blocker chloroethylclonidine. The Na+/K+-ATPase inhibitor ouabain attenuated K+-elicited vasodilation, and ouabain with Ba2+ abolished the response. Transfection of arterioles with Kir2.1 antisense oligonucleotides abolished sustained but not transient dilation. It is concluded that extraluminal K+ elevation within the physiological range induces initial transient dilation of porcine coronary arterioles by activating smooth muscle Na+/K+-ATPase and sustained dilation via smooth muscle Kir2.1 channels.
- Open Access
- 2 January 2025
- Published by MDPI AG in Preprints.org
Activation of Smooth Muscle Kir2.1 Channels and Na+/K+ ATPase Mediates Dilation of Porcine Coronary Arterioles to Potassium
Metabolic stress on the heart can cause dilation of coronary arterioles for blood flow recruitment. Although potassium ions (K+) released from the myocardium are a major mediator for this response, the underlying signaling pathways for vasodilation are incompletely understood. Herein, roles of smooth muscle inward-rectifier K+ channel subtype 2.1 (Kir2.1) and Na+/K+ ATPase were examined. Porcine coronary arterioles were isolated, cannulated, and pressurized for vasomotor study. Vessels developed basal tone and dilated concentration-dependently to extraluminal K+ from 7 to 20 mM. Higher K+ concentrations (25-40 mM) caused graded vasoconstriction. Vasodilation to K+ (10 mM) was not altered by endothelial removal, and blockade of ATP-sensitive K+ channels, voltage-sensitive K+ channels, or calcium-activated K+ channels did not affect K+-induced vasodilation. However, sustained but not abrupt transient vasodilation to K+ was reduced by nonspecific Kir channel inhibitor Ba2+ or specific Kir2.1 channel blocker chloroethylclonidine. The Na+/K+ ATPase inhibitor ouabain attenuated K+-elicited vasodilation, and ouabain with Ba2+ abolished the response. Transfection of arterioles with Kir2.1 antisense oligonucleotides abolished sustained but not transient dilation. It is concluded that extraluminal K+ elevation within the physiological range induces initial transient dilation of porcine coronary arterioles by activating Na+/K+ ATPase and sustained dilation via smooth muscle Kir2.1 channels.
- 2 January 2025
- Published by MDPI AG in Preprints.org
Open AccessActivation of Smooth Muscle Kir2.1 Channels and Na+/K+ ATPase Mediates Dilation of Porcine Coronary Arterioles to Potassium
Metabolic stress on the heart can cause dilation of coronary arterioles for blood flow recruitment. Although potassium ions (K+) released from the myocardium are a major mediator for this response, the underlying signaling pathways for vasodilation are incompletely understood. Herein, roles of smooth muscle inward-rectifier K+ channel subtype 2.1 (Kir2.1) and Na+/K+ ATPase were examined. Porcine coronary arterioles were isolated, cannulated, and pressurized for vasomotor study. Vessels developed basal tone and dilated concentration-dependently to extraluminal K+ from 7 to 20 mM. Higher K+ concentrations (25-40 mM) caused graded vasoconstriction. Vasodilation to K+ (10 mM) was not altered by endothelial removal, and blockade of ATP-sensitive K+ channels, voltage-sensitive K+ channels, or calcium-activated K+ channels did not affect K+-induced vasodilation. However, sustained but not abrupt transient vasodilation to K+ was reduced by nonspecific Kir channel inhibitor Ba2+ or specific Kir2.1 channel blocker chloroethylclonidine. The Na+/K+ ATPase inhibitor ouabain attenuated K+-elicited vasodilation, and ouabain with Ba2+ abolished the response. Transfection of arterioles with Kir2.1 antisense oligonucleotides abolished sustained but not transient dilation. It is concluded that extraluminal K+ elevation within the physiological range induces initial transient dilation of porcine coronary arterioles by activating Na+/K+ ATPase and sustained dilation via smooth muscle Kir2.1 channels.
- 3 October 2024
- Published by American Society of Hematology in Blood
- Vol. 144 (14) , 1543
A rare glimpse of Fessas bodies in a patient with β-thalassemia major postsplenectomy
- 3 October 2024
- Published by American Society of Hematology in Blood
- Vol. 144 (14) , 1543
A rare glimpse of Fessas bodies in a patient with β-thalassemia major postsplenectomy
- 30 September 2024
- Published by Elsevier in The Lancet Oncology
- Vol. 25 (10) , e526
IVLBCL mimicking VEXAS syndrome
- 30 September 2024
- Published by Elsevier in The Lancet Oncology
- Vol. 25 (10) , e526
IVLBCL mimicking VEXAS syndrome
- Open Access
- 22 July 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (7) , e9139
A case of AML with complex karyotype and chromosomal rearrangement of KMT2A
Key Clinical Message: This is a case of an elderly patient diagnosed with acute myeloid leukemia (AML). While morphological findings, including numerous long, slender, cigar‐shaped Auer rods, suggested AML with t(8;21), cytogenetic and FISH analysis revealed abnormalities in chromosome 11 and the KMT2A (MLL) gene. The patient also exhibited double minutes, typically seen in AML and linked to a complex karyotype and poor prognosis. Correlating morphological findings with molecular genetics and cytogenetics is crucial for accurate diagnosis and treatment.
- 22 July 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (7) , e9139
Open AccessA case of AML with complex karyotype and chromosomal rearrangement of KMT2A
Key Clinical Message: This is a case of an elderly patient diagnosed with acute myeloid leukemia (AML). While morphological findings, including numerous long, slender, cigar‐shaped Auer rods, suggested AML with t(8;21), cytogenetic and FISH analysis revealed abnormalities in chromosome 11 and the KMT2A (MLL) gene. The patient also exhibited double minutes, typically seen in AML and linked to a complex karyotype and poor prognosis. Correlating morphological findings with molecular genetics and cytogenetics is crucial for accurate diagnosis and treatment.
- Open Access
- 1 November 2023
- Published by Wiley in Case Reports in Hematology
- Vol. 2023, 1-4
A Case of Acute Myeloid Leukemia Mimicking Blastic Plasmacytoid Dendritic Cell Neoplasm: Utility of the Proposed Upcoming WHO-5 Diagnostic Criteria
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy which is associated with a distinctive morphologic appearance. However, the morphology is not specific, and diagnostic characterization requires integration of immunophenotypic and genetic testing. We herein report a case of a 35-year-old female patient who presented with worsening cytopenia. A bone marrow aspirate identified medium-sized blastic cells with perinuclear microvacuoles (pearl neckless). Occasional blasts demonstrated a hand mirror appearance. Tandem flow cytometry showed an atypical population of dim CD45 events with expression of CD4, CD56, CD117, CD123, and monocytic markers such as CD64. Fluorescence in situ hybridization (FISH) showed evidence of a KMT2A rearrangement with an unknown partner on chromosome 19. Expression of MPO and muramidase was present. The final diagnosis was acute monocytic leukemia (AMoL). Due to the overlapping features of acute myeloid leukemia and BPDCN, the 5th Edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours provides new criteria for the diagnosis of BPDCN. Our case highlights the utility of these criteria.
- 1 November 2023
- Published by Wiley in Case Reports in Hematology
- Vol. 2023, 1-4
Open AccessA Case of Acute Myeloid Leukemia Mimicking Blastic Plasmacytoid Dendritic Cell Neoplasm: Utility of the Proposed Upcoming WHO-5 Diagnostic Criteria
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy which is associated with a distinctive morphologic appearance. However, the morphology is not specific, and diagnostic characterization requires integration of immunophenotypic and genetic testing. We herein report a case of a 35-year-old female patient who presented with worsening cytopenia. A bone marrow aspirate identified medium-sized blastic cells with perinuclear microvacuoles (pearl neckless). Occasional blasts demonstrated a hand mirror appearance. Tandem flow cytometry showed an atypical population of dim CD45 events with expression of CD4, CD56, CD117, CD123, and monocytic markers such as CD64. Fluorescence in situ hybridization (FISH) showed evidence of a KMT2A rearrangement with an unknown partner on chromosome 19. Expression of MPO and muramidase was present. The final diagnosis was acute monocytic leukemia (AMoL). Due to the overlapping features of acute myeloid leukemia and BPDCN, the 5th Edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours provides new criteria for the diagnosis of BPDCN. Our case highlights the utility of these criteria.
- Open Access
- 29 May 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (6)
A case of MDS/MPN overlap syndrome with ring sideroblasts and thrombocytosis: Tackling the quandary of thrombosis versus hemorrhage
Key Clinical Message: No formal treatment guidelines for MDS/MPN‐RS‐T exist. With salient features such as anemia and thrombocytosis, management is individualized and aims to address anemia, thrombosis, and in some cases acquired von Willebrand's disease. Myelodysplastic/myeloproliferative overlap syndrome with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T) is a rare myeloid neoplasm showing myelodysplastic and myeloproliferative features. With extremely raised platelets, possibility of acquired von Willebrand and risk of hemorrhage is increased. With this quandary in mind, a descriptive case and a brief discussion of available treatments ensues.
- 29 May 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (6)
Open AccessA case of MDS/MPN overlap syndrome with ring sideroblasts and thrombocytosis: Tackling the quandary of thrombosis versus hemorrhage
Key Clinical Message: No formal treatment guidelines for MDS/MPN‐RS‐T exist. With salient features such as anemia and thrombocytosis, management is individualized and aims to address anemia, thrombosis, and in some cases acquired von Willebrand's disease. Myelodysplastic/myeloproliferative overlap syndrome with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T) is a rare myeloid neoplasm showing myelodysplastic and myeloproliferative features. With extremely raised platelets, possibility of acquired von Willebrand and risk of hemorrhage is increased. With this quandary in mind, a descriptive case and a brief discussion of available treatments ensues.